MENU
+Compare
VERU
Stock ticker: NASDAQ
AS OF
Sep 17, 04:59 PM (EDT)
Price
$3.44
Change
-$0.25 (-6.79%)
Capitalization
53.91M

VERU Veru Inc Forecast, Technical & Fundamental Analysis

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS)... Show more

VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VERU with price predictions
Sep 16, 2025

Momentum Indicator for VERU turns positive, indicating new upward trend

VERU saw its Momentum Indicator move above the 0 level on September 10, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VERU's RSI Oscillator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 72 cases where VERU's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VERU just turned positive on August 22, 2025. Looking at past instances where VERU's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VERU advanced for three days, in of 233 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VERU broke above its upper Bollinger Band on September 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VERU entered a downward trend on August 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VERU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.265) is normal, around the industry mean (20.607). P/E Ratio (0.570) is within average values for comparable stocks, (53.283). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.160). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (2.755) is also within normal values, averaging (333.412).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VERU is expected to report earnings to fall 88.66% to -5 cents per share on December 01

Veru Inc VERU Stock Earnings Reports
Q3'25
Est.
$-0.06
Q2'25
Missed
by $0.45
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.01
The last earnings report on August 12 showed earnings per share of -50 cents, missing the estimate of -5 cents. With 109.13K shares outstanding, the current market capitalization sits at 53.91M.
A.I.Advisor
published Dividends

VERU paid dividends on May 07, 2014

Veru Inc VERU Stock Dividends
А dividend of $0.01 per share was paid with a record date of May 07, 2014, and an ex-dividend date of April 28, 2014. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of female condoms

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Household Or Personal Care
Address
2916 North Miami Avenue
Phone
+1 305 509-6897
Employees
189
Web
https://www.verupharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCSHF8.73N/A
N/A
Lancashire Holdings Ltd.
ERRAF18.01N/A
N/A
Emera Inc.
PCELF3.00N/A
N/A
Powercell Sweden AB
SWGNF38.56N/A
N/A
Swatch Group AG
AKCCF0.03N/A
N/A
AKER CARBON CAPTURE ASA

VERU and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with PXXLF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then PXXLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
+3.95%
PXXLF - VERU
37%
Loosely correlated
N/A
PRAX - VERU
35%
Loosely correlated
+3.83%
SRRK - VERU
32%
Poorly correlated
-3.95%
COGT - VERU
32%
Poorly correlated
+1.05%
SPHDF - VERU
31%
Poorly correlated
N/A
More